Selected research
Industry Growth & Trends
Global Flu Shots Industry Growth and Trends Forecast to 2032
Market perspective
The global Flu Shots market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Flu Shots is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Flu Shots is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Flu Shots is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Flu Shots include SANOFI, GSK, VAXTEC, TIANYUAN BIO-PHARMA, SIOBP, SINOVAC, LANZHOU INSTITUTE OF BIOLOGICAL PRODUCT, HUALAN BIO and CHANGSHENG, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Flu Shots market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Flu Shots market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Flu Shots market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Flu Shots.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Flu Shots market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Flu Shots Market by Company
SANOFI
GSK
VAXTEC
TIANYUAN BIO-PHARMA
SIOBP
SINOVAC
LANZHOU INSTITUTE OF BIOLOGICAL PRODUCT
HUALAN BIO
CHANGSHENG
CCBIO
ALEPH BIOMEDICAL
Flu Shots Segment by Type
Influenza Whole Virus Vaccines
Influenza Virus Subunit Vaccines
Influenza Virus Split Vaccines
Flu Shots Segment by Application
Avian Influenza Virus-A
Avian Influenza Virus-B
Flu Shots Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Flu Shots market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Flu Shots and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Flu Shots.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Flu Shots manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Flu Shots in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Influenza Whole Virus Vaccines
- Influenza Virus Subunit Vaccines
- Influenza Virus Split Vaccines
Applications
- Avian Influenza Virus-A
- Avian Influenza Virus-B
Companies covered
- SANOFI
- GSK
- VAXTEC
- TIANYUAN BIO-PHARMA
- SIOBP
- SINOVAC
- LANZHOU INSTITUTE OF BIOLOGICAL PRODUCT
- HUALAN BIO
- CHANGSHENG
- CCBIO
- ALEPH BIOMEDICAL
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Flu Shots Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Flu Shots Sales Estimates and Forecasts (2021-2032)
- 1.3 Flu Shots Market by Type
- 1.3.1 Influenza Whole Virus Vaccines
- 1.3.2 Influenza Virus Subunit Vaccines
- 1.3.3 Influenza Virus Split Vaccines
- 1.4 Global Flu Shots Market Size by Type
- 1.4.1 Global Flu Shots Market Size Overview by Type (2021-2032)
- 1.4.2 Global Flu Shots Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Flu Shots Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Flu Shots Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Flu Shots Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Flu Shots Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Flu Shots Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Flu Shots Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Flu Shots Industry Trends
- 2.2 Flu Shots Industry Drivers
- 2.3 Flu Shots Industry Opportunities and Challenges
- 2.4 Flu Shots Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Flu Shots Revenue (2021-2026)
- 3.2 Global Top Players by Flu Shots Sales (2021-2026)
- 3.3 Global Top Players by Flu Shots Price (2021-2026)
- 3.4 Global Flu Shots Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Flu Shots Major Company Production Sites & Headquarters
- 3.6 Global Flu Shots Company, Product Type & Application
- 3.7 Global Flu Shots Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Flu Shots Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Flu Shots Players Market Share by Revenue in 2025
- 3.8.3 2025 Flu Shots Tier 1, Tier 2, and Tier 3
4 Flu Shots Regional Status and Outlook
- 4.1 Global Flu Shots Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Flu Shots Historic Market Size by Region
- 4.2.1 Global Flu Shots Sales in Volume by Region (2021-2026)
- 4.2.2 Global Flu Shots Sales in Value by Region (2021-2026)
- 4.2.3 Global Flu Shots Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Flu Shots Forecasted Market Size by Region
- 4.3.1 Global Flu Shots Sales in Volume by Region (2027-2032)
- 4.3.2 Global Flu Shots Sales in Value by Region (2027-2032)
- 4.3.3 Global Flu Shots Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Flu Shots by Application
- 5.1 Flu Shots Market by Application
- 5.1.1 Avian Influenza Virus-A
- 5.1.2 Avian Influenza Virus-B
- 5.2 Global Flu Shots Market Size by Application
- 5.2.1 Global Flu Shots Market Size Overview by Application (2021-2032)
- 5.2.2 Global Flu Shots Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Flu Shots Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Flu Shots Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Flu Shots Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Flu Shots Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Flu Shots Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Flu Shots Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 SANOFI
- 6.1.1 SANOFI Company Information
- 6.1.2 SANOFI Business Overview
- 6.1.3 SANOFI Flu Shots Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 SANOFI Flu Shots Product Portfolio
- 6.1.5 SANOFI Recent Developments
- 6.2 GSK
- 6.2.1 GSK Company Information
- 6.2.2 GSK Business Overview
- 6.2.3 GSK Flu Shots Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 GSK Flu Shots Product Portfolio
- 6.2.5 GSK Recent Developments
- 6.3 VAXTEC
- 6.3.1 VAXTEC Company Information
- 6.3.2 VAXTEC Business Overview
- 6.3.3 VAXTEC Flu Shots Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 VAXTEC Flu Shots Product Portfolio
- 6.3.5 VAXTEC Recent Developments
- 6.4 TIANYUAN BIO-PHARMA
- 6.4.1 TIANYUAN BIO-PHARMA Company Information
- 6.4.2 TIANYUAN BIO-PHARMA Business Overview
- 6.4.3 TIANYUAN BIO-PHARMA Flu Shots Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 TIANYUAN BIO-PHARMA Flu Shots Product Portfolio
- 6.4.5 TIANYUAN BIO-PHARMA Recent Developments
- 6.5 SIOBP
- 6.5.1 SIOBP Company Information
- 6.5.2 SIOBP Business Overview
- 6.5.3 SIOBP Flu Shots Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 SIOBP Flu Shots Product Portfolio
- 6.5.5 SIOBP Recent Developments
- 6.6 SINOVAC
- 6.6.1 SINOVAC Company Information
- 6.6.2 SINOVAC Business Overview
- 6.6.3 SINOVAC Flu Shots Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 SINOVAC Flu Shots Product Portfolio
- 6.6.5 SINOVAC Recent Developments
- 6.7 LANZHOU INSTITUTE OF BIOLOGICAL PRODUCT
- 6.7.1 LANZHOU INSTITUTE OF BIOLOGICAL PRODUCT Company Information
- 6.7.2 LANZHOU INSTITUTE OF BIOLOGICAL PRODUCT Business Overview
- 6.7.3 LANZHOU INSTITUTE OF BIOLOGICAL PRODUCT Flu Shots Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 LANZHOU INSTITUTE OF BIOLOGICAL PRODUCT Flu Shots Product Portfolio
- 6.7.5 LANZHOU INSTITUTE OF BIOLOGICAL PRODUCT Recent Developments
- 6.8 HUALAN BIO
- 6.8.1 HUALAN BIO Company Information
- 6.8.2 HUALAN BIO Business Overview
- 6.8.3 HUALAN BIO Flu Shots Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 HUALAN BIO Flu Shots Product Portfolio
- 6.8.5 HUALAN BIO Recent Developments
- 6.9 CHANGSHENG
- 6.9.1 CHANGSHENG Company Information
- 6.9.2 CHANGSHENG Business Overview
- 6.9.3 CHANGSHENG Flu Shots Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 CHANGSHENG Flu Shots Product Portfolio
- 6.9.5 CHANGSHENG Recent Developments
- 6.10 CCBIO
- 6.10.1 CCBIO Company Information
- 6.10.2 CCBIO Business Overview
- 6.10.3 CCBIO Flu Shots Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 CCBIO Flu Shots Product Portfolio
- 6.10.5 CCBIO Recent Developments
- 6.11 ALEPH BIOMEDICAL
- 6.11.1 ALEPH BIOMEDICAL Company Information
- 6.11.2 ALEPH BIOMEDICAL Business Overview
- 6.11.3 ALEPH BIOMEDICAL Flu Shots Sales, Revenue and Gross Margin (2021-2026)
- 6.11.4 ALEPH BIOMEDICAL Flu Shots Product Portfolio
- 6.11.5 ALEPH BIOMEDICAL Recent Developments
7 North America by Country
- 7.1 North America Flu Shots Sales by Country
- 7.1.1 North America Flu Shots Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Flu Shots Sales by Country (2021-2026)
- 7.1.3 North America Flu Shots Sales Forecast by Country (2027-2032)
- 7.2 North America Flu Shots Market Size by Country
- 7.2.1 North America Flu Shots Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Flu Shots Market Size by Country (2021-2026)
- 7.2.3 North America Flu Shots Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Flu Shots Sales by Country
- 8.1.1 Europe Flu Shots Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Flu Shots Sales by Country (2021-2026)
- 8.1.3 Europe Flu Shots Sales Forecast by Country (2027-2032)
- 8.2 Europe Flu Shots Market Size by Country
- 8.2.1 Europe Flu Shots Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Flu Shots Market Size by Country (2021-2026)
- 8.2.3 Europe Flu Shots Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Flu Shots Sales by Country
- 9.1.1 Asia-Pacific Flu Shots Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Flu Shots Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Flu Shots Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Flu Shots Market Size by Country
- 9.2.1 Asia-Pacific Flu Shots Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Flu Shots Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Flu Shots Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Flu Shots Sales by Country
- 10.1.1 South America Flu Shots Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Flu Shots Sales by Country (2021-2026)
- 10.1.3 South America Flu Shots Sales Forecast by Country (2027-2032)
- 10.2 South America Flu Shots Market Size by Country
- 10.2.1 South America Flu Shots Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Flu Shots Market Size by Country (2021-2026)
- 10.2.3 South America Flu Shots Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Flu Shots Sales by Country
- 11.1.1 Middle East and Africa Flu Shots Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Flu Shots Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Flu Shots Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Flu Shots Market Size by Country
- 11.2.1 Middle East and Africa Flu Shots Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Flu Shots Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Flu Shots Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Flu Shots Value Chain Analysis
- 12.1.1 Flu Shots Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Flu Shots Production Mode & Process
- 12.2 Flu Shots Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Flu Shots Distributors
- 12.2.3 Flu Shots Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst